December 6, 2018
Chugai Pharmaceutical filed a lawsuit on December 5 against the Japan arm of Alexion Pharmaceuticals claiming the US company’s anti-C5 antibody ALXN1210 (ravulizumab) infringes Chugai’s patents, it said on the same day. The move comes weeks after the Japanese company...read more